Literature DB >> 23290984

Photoreceptor outer segment length: a prognostic factor for idiopathic epiretinal membrane surgery.

Akira Shiono1, Jiro Kogo, Gerd Klose, Hiroyuki Takeda, Hiroki Ueno, Naoto Tokuda, Jun Inoue, Akiko Matsuzawa, Naoyuki Kayama, Satoki Ueno, Hitoshi Takagi.   

Abstract

PURPOSE: To investigate prognostic factors for visual improvement in patients undergoing vitrectomy for epiretinal membrane (ERM) using spectral domain (SD) optical coherence tomography (OCT).
DESIGN: Prospective cohort study. PARTICIPANTS: A total of 41 eyes of 38 patients.
METHODS: A total of 41 eyes of 38 patients with idiopathic ERM underwent ERM resection. Ophthalmic evaluations included best-corrected visual acuity (BCVA) and OCT parameters before and 1, 3, and 6 months after surgery. Correlations between OCT parameters and BCVA were assessed at each time point. Correlations between postoperative BCVA and preoperative factors were evaluated, including age, preoperative BCVA, photoreceptor outer segment (PROS) length, central foveal thickness (CFT), outer foveal thickness (OFT), and outer nuclear layer thickness (ONLT). The factors influencing postoperative BCVA were evaluated using multiple regression analysis. MAIN OUTCOME MEASURES: The BCVA at 6 months postoperatively.
RESULTS: The PROS length had the most significant correlation with BCVA at each time point (baseline: P = 0.0098, r = -0.409; 1 month: P = 0.0002, r = -0.586; 3 months: P < 0.0001, r = -0.642; 6 months: P = 0.0002, r = -0.577). The PROS length 1 month postoperatively was significantly decreased compared with that preoperatively (P = 0.0325), and the PROS length at 3 months recovered to the baseline length. Preoperative BCVA and PROS length were significantly correlated with postoperative BCVA at 6 months (P = 0.0055, r = 0.439 and P = 0.0089, r = -0.414, respectively). Other parameters, including age, CFT, OFT, and ONLT, were not significantly correlated with postoperative BCVA. Multiple regression analysis showed that preoperative PROS length yielded the highest regression coefficient with postoperative BCVA (P = 0.0363, standard regression coefficient = -0.335, overall R(2) = 0.289).
CONCLUSIONS: Imaging of PROS length with SD-OCT was found to be a good indicator of BCVA at each time point after surgery and a predictor of postoperative BCVA in patients with idiopathic ERM. The PROS length changes after surgery may indicate surgical injury and restoration of the macular outer layer.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23290984     DOI: 10.1016/j.ophtha.2012.09.044

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  45 in total

1.  Two-year results of metamorphopsia, visual acuity, and optical coherence tomographic parameters after epiretinal membrane surgery.

Authors:  Takamasa Kinoshita; Hiroko Imaizumi; Hirotomo Miyamoto; Takashi Katome; Kentaro Semba; Yoshinori Mitamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-08-30       Impact factor: 3.117

2.  Retinal outer layer thickness increases after vitrectomy for epiretinal membrane, and visual improvement positively correlates with photoreceptor outer segment length.

Authors:  Yuki Hashimoto; Wataru Saito; Michiyuki Saito; Kiriko Hirooka; Akio Fujiya; Chikako Yoshizawa; Kousuke Noda; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-06       Impact factor: 3.117

3.  Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane.

Authors:  Rino Frisina; Sajish J Pinackatt; Mauro Sartore; Alessandro Monfardini; Andrea Baldi; Bruno Mario Cesana; Francesco Semeraro; Adriana Bratu; Barbara Parolini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-25       Impact factor: 3.117

Review 4.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

5.  Quantitative analysis of external limiting membrane, ellipsoid zone and interdigitation zone defects in patients with macular holes.

Authors:  Jacques Ramos Houly; Carlos Eduardo Veloso; Elke Passos; Márcio Bittar Nehemy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-15       Impact factor: 3.117

6.  Relationship between foveal microstructures and visual outcomes in eyes with resolved central serous chorioretinopathy.

Authors:  Taiji Hasegawa; Masahiro Okamoto; Naonori Masuda; Tetsuo Ueda; Nahoko Ogata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-31       Impact factor: 3.117

7.  Analysis of the ganglion cell layer and photoreceptor layer using optical coherence tomography after idiopathic epiretinal membrane surgery.

Authors:  Sung Who Park; Ik Soo Byon; Ho Yun Kim; Ji Eun Lee; Boo Sup Oum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-20       Impact factor: 3.117

8.  Reflectivity and thickness analysis of epiretinal membranes using spectral-domain optical coherence tomography.

Authors:  Ajay E Kuriyan; Delia Cabrera DeBuc; William E Smiddy
Journal:  Int J Ophthalmol       Date:  2016-02-18       Impact factor: 1.779

9.  Evaluation of postoperative visual function based on the preoperative inner layer structure in the epiretinal membrane.

Authors:  Hiroko Terashima; Fumiki Okamoto; Hiruma Hasebe; Naoki Matsuoka; Eriko Ueda; Hiromitsu Yoshida; Tetsuya Togano; Takeo Fukuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-07       Impact factor: 3.117

10.  Photoreceptor inner and outer segment layer thickness in multiple evanescent white dot syndrome.

Authors:  Rei Arai; Itaru Kimura; Yutaka Imamura; Kei Shinoda; Celso Soiti Matsumoto; Keisuke Seki; Masahiro Ishida; Akira Murakami; Atsushi Mizota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-01       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.